<?xml version="1.0" encoding="UTF-8"?>
<ref id="B109-vaccines-08-00098">
 <label>109.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dagur</surname>
    <given-names>R.S.</given-names>
   </name>
   <name>
    <surname>Branch-Woods</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Mathews</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Joshi</surname>
    <given-names>P.S.</given-names>
   </name>
   <name>
    <surname>Quadros</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Harms</surname>
    <given-names>D.W.</given-names>
   </name>
   <name>
    <surname>Cheng</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Miles</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Pirruccello</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Gurumurthy</surname>
    <given-names>C.B.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Human-like NSG mouse glycoproteins sialylation pattern changes the phenotype of human lymphocytes and sensitivity to HIV-1 infection</article-title>
  <source>BMC Immunol.</source>
  <year>2019</year>
  <volume>20</volume>
  <elocation-id>2</elocation-id>
  <pub-id pub-id-type="doi">10.1186/s12865-018-0279-3</pub-id>
  <?supplied-pmid 30616506?>
  <pub-id pub-id-type="pmid">30616506</pub-id>
 </element-citation>
</ref>
